ASRS
STOK icon

Arizona State Retirement System’s Stoke Therapeutics STOK Stock Holding History

Arizona State Retirement System’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
10,201
-781
-7% -$25.1K ﹤0.01% 1739
2026
Q1 		$358K Buy
10,982
+46
+0.4% +$1.51K ﹤0.01% 1645
2025
Q4 		$347K Sell
10,936
-358
-3% -$10.8K ﹤0.01% 1686
2025
Q3 		$265K Buy
+11,294
New +$194K ﹤0.01% 1839

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arizona State Retirement System's STOK Position: Q2 2026 in Review

Arizona State Retirement System reduced its Stoke Therapeutics (STOK) stake by 7.1% in Q2 2026, selling an estimated $25.1K and leaving 10,201 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Arizona State Retirement System first reported a position in STOK in Q3 2025 and has held it in 4 quarters since. The position peaked at $358K in Q1 2026. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Arizona State Retirement System held 10,201 shares of Stoke Therapeutics worth $334K as of Q2 2026.
  • Arizona State Retirement System sold 781 Stoke Therapeutics shares in Q2 2026, an estimated $25.1K.
  • Stoke Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1739 holding.
  • Arizona State Retirement System first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Arizona State Retirement System's Stoke Therapeutics position peaked at $358K in Q1 2026.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.